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2-Amino-3-methylimidazo[4,5-fiquinoline
(IQ) is one of 19 heterocyclic aromatic
amines (HAAs) formed during the cooking
offish, fowl, pork, and beefand isolated as
mutagens using the Ames Salmonella
typhimurium assay (1,2). Although the
HAAs thus far identified are present in the
Western diet in only small amounts (nano-
grams per gram), they are among the most
potent mutagens identified and may be of
importance in the etiology ofsome human
cancers (3). Ten of these food mutagens
including IQ have been shown to be car-
cinogenic when administered to mice and
rats (4-8). IQ was found to induce tumors
ofthe liver, lung, and forestomach in mice
and ofthe small and large intestine, mam-
mary gland, liver, oral cavity, and Zymbal
gland in rats (4,5,8). Based on chemical
structure, mutagenic activity in vitro, con-
centration in cooked foods, carcinogenic
activity in rodents, and availability, we
selected three compounds for study in
nonhuman primates: IQ, 2-amino-3,8-
dimethylimidazo[4,5-flquinoxaline (8-
MeIQx), and 2-amino-1-methyl-6-phenyl-
imidazo[4,5,b]pyridine (PhIP) (9). Our
initial report described tumors induced in
three macaques by IQ as part of an ongo-
ing study (JO). This paper reports on hepa-
tocellular carcinoma induced in a high per-
centage of macaques by IQ after oral
administration.
Materials and Methods
Macaques assigned to this study were born
in a closed colony, reared by their mothers,
and were assigned to this study as they
became approximately 1 year of age. The
monkeys were primarily cynomolgus (Mac-
acafascularis), but two rhesus (M mulatto)
were also used at the high dose. The ani-
mals were housed in individual stainless-
steel cages that were wall mounted and
equipped with an automatic watering
device. Purina High Protein Monkey
Chow #5045 was offered twice daily, and
the animals also received a vitamin sand-
wich and a portion of an apple daily. IQ
was purchased from the Nard Institute
Ltd. (Osaka, Japan) and kept refrigerated
in a desiccator until use. IQ was prepared
daily as a suspension in hydroxypropylcel-
lulose (HPC) and administered by gavage
five times a week (Monday-Friday) at a
dose of 10 or 20 mg/kg body weight.
Twenty animals were assigned to each
dose. The monkeys receiving 10 mg/kg IQ
were all cynomolgus and consisted of 12
males and 8 females. Two rhesus females
and 18 cynomolgus (8 males and 10 fe-
males) monkeys received 20 mg/kg IQ.
There were three sources ofcontrols: 9
concurrent HPC cynomolgus monkeys
dosed by gavage, 3 historical HPC cy-
nomolgus monkeys fed HPC in a prune
for over 16 years and still on HPC treat-
ment, and 5 cynomolgus untreated con-
current controls.
We observed all IQtreated and control
animals daily and measured body weight
weekly. Blood was drawn every 3 months
for routine hematology and clinical chem-
istry values as well as a-fetoprotein (AFP)
measurements, which were determined by
radioimmunoassay using monkey AFP as
antigen. Liver palpation and laparoscopy
were performed at 3- to 6-month intervals.
The tumor bearing animals were eutha-
nized with an overdose of sodium pento-
barbital and carefully necropsied. Tissues
from all the organs were subjected to
histopathological examination.
Results
Table 1 summarizes the number of ma-
caques with tumors induced by IQ as of 1
July 1993. Eleven monkeys (55%) had
liver tumors induced at the 10 mg/kg dose
level and 19 (95%) at the 20 mg/kg dose
level. Both male and female monkeys were
susceptible to the compound. Table 2 sum-
marizes the average total dose from time of
initiation oftreatment until time oftumor
development (as indicated by histopatholo-
gy following biopsy or at necropsy). The
animals at 20 mg/kg received a higher aver-
age total dose (45.1 g) than the 10 mg/kg
group (39.7 g) and also had a shorter latent
period for tumor induction (i.e., 43
months versus 59 months; Table 2). The
shortest latent period was 27 months at the
20 mg/kg dose level, and thus far the
longest latent period was 83 months at the
10 mg/kg dose (Table 2). However, several
animals at the 10 mg/kg dose level have
exceeded 83 months ofexposure to IQand
are alive without evidence of tumor. One
animal at the 20 mg/kg dose level remains
on study with no evidence of gross liver
pathology after 91 months and a total dose
of 110 g. Seven animals remain on the
study at the 10 mg/kg dose level without
evidence oftumor. Two ofthe monkeys at
the 10 mg/kg level have died without
tumor. One died as a result ofbloat which
was not compound related, and the other
died as a result of thrombocytopenia. At
the present time, it cannot be ruled out
that the low platelet counts were com-
pound related. Generally, liver function
tests were not helpful for diagnosing liver
cancer, and abnormal values were found
subsequent to tumor detection by lapro-
scopic examinations.
All the IQ-induced primary tumors
were found in the liver. As indicated in
Table 1, neither the HPC concurrent con-
trols, the historic HPC controls, nor the
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Table 1. Malignant livertumors induced by IQ in nonhuman primates
Compound No. treated No. withtumors % with tumors
IQ,10 mg/kg 20 11 (3females,8 males) 55
IQ, 20 mg/kg 20 19 (11 females, 8 males) 95
HPC concurrent controls 9 0 0
HPC historical controls 3 0 0
Untreated controls 5 0 0
HPC, hydroxypropylcellulose.
Table 2. Dose and latent period for induction ofhepatocellular carcinoma in nonhuman primates
Average total dose of Average latent period
Compound IQ attumor diagnosis (g) fortumor induction (months)
IQ, 10 mg/kg 39.7 (22-55)a 59.6(36-83)
IQ, 20 mg/kg 45.1 (19 82)b 43.4 (27-68)
aRanges in parentheses.
bFigures are forthe cynomolgus monkeys; the values forthe two rhesus females with hepatocellular car-
cinoma are 76 g and 91 g total dose with a 56-month and 51-month latent period fortumor inductions.
untreated concurrent controls had tumors
of any type. Furthermore, the tumor inci-
dence for all types ofmalignant neoplasms
in the breeders, solvent and untreated con-
trols ofthis colony during the past 32 years
was 1.5% for cynomolgus monkeys (total
of 130 animals) and 2.8% for rhesus mon-
keys (total 181 animals). None of these
tumor were hepatocellular carcinomas.
A_
The extent of malignant tumor in-
volvement ofthe liver varied, ranging from
a solitary, well-circumscribed nodule (Fig.
1) to a massive destruction of all lobes of
the liver by numerous tumor nodules (Fig.
2). Most of the tumor nodules were well
defined and soft with areas ofnecrosis and
hemorrhage. In one ofthe cases, there was
gross evidence of tumor invasion of the
superior vena cava. Lung metastases were
detected in two of the animals (both
males) at the 10 mg/kg dose and four (two
males and two females) at the 20 mg/kg
dose. In the first animal that was diagnosed
with metastatic hepatocellular carcinoma
after a latent period of 27 months, there
was evidence of local invasion into the
muscular layer ofthe stomach, in addition
to metastases to lungs and hilar lymph
nodes.
Microscopically, all the malignant liver
tumors were of hepato-biliary origin. The
majority of the tumor nodules were hepa-
tocellular carcinomas, with trabecular pat-
tern being the most common (Fig. 3).
However, among the five cases with mas-
sive tumor involvement, as depicted in
Figure 2, the histological growth pattern of
hepatocellular carcinoma (Fig.4) and the
lung metastasis (Fig.5) was moderately to
poorly differentiated and showed little
resemblance to normal liver cells. In several
ofthe livers with multiple tumors, individ-
ual nodules were composed ofmixed hepa-
tocellular and cholangiocarcinoma. Histo-
logical variants, such as clear cell and scir-
rhous types of hepatocellular carcinomas,
B
Figure 1. Gross appearance ofthe anterior surface (A) and cross section (B) of
the liver from case no. 1416CC. Two well-defined nodules of hepatocellular
carcinoma were present;the larger one (3.5 cm in diameter) is seen protruding
fromthe anteriorsurface ofthe rightsuperior lobe.
Figure 2. Gross appearance ofthe anterior surface (A) and cross section (B) of
the liverfrom case no. 1423CC. The liver shows massive involvement by hepato-
cellular carcinoma. The largest mass (7 cm in diameter) is located in the right
superior lobe, and numerous smaller nodules are presentthroughoutthe liver.
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Figure 3. Microscopic appearance of a livertumor nodule from case no. 1416CC
showing a trabecular pattern of well-differentiated hepatocellular carcinoma
(1Ox, hematoxylin-eosin).
Figure 4. Microscopic appearance of a representative tumor nodule from case
no. 1423CC. Solid nests of moderately to poorly differentiated hepatocellular
carcinoma are surrounded by bands of connective tissue (lOOx, hematoxylin-
eosin).
Figure 5. Microscopic appearance of a lung nodule from case no. 1423CC,
showing metastatic hepatocellular carcinoma (50x, hematoxylin-eosin).
were detected in rare instances. There was
microscopic evidence ofintrahepatic vascu-
lar invasion in approximately 50% of the
cases, and in the livers with massive tumor
involvement extensive intravascular tumor
thrombi were seen. In contrast to rodent
hepatocarcinogenesis models, hyperplastic
nodules were not identified before gross
tumor development. In the IQ-treated
monkeys, pinpoint 1-2 mm light-tan
lesions were seen during laparoscopic
examination and at necropsy. Micro-
scopically, these lesions were composed of
glycogen-filled hepatocytes with small
eccentric nuclei. It remains to be deter-
mined ifthese clear-cell foci have any rela-
tionship with the carcinogenic process.
Discussion
During the past decade, several highly
mutagenic HAAs have been identified in
cooked beef, pork, fish, and fowl (1,2).
These compounds are formed during nor-
mal cooking practices such as frying, broil-
ing, or grilling. The three compounds
selected for study in nonhuman primates,
IQ, 8-MeIQx, and PhIP, are representative
of the most prevalent class of HAAs pre-
sent in the Western diet. Ten ofthe HAAs
that have been evaluated in rodents are car-
cinogenic, including IQ, but the degree to
which these data should be extrapolated to
the human population is debatable.
Results presented in this paper demon-
strate convincing evidence that the food
mutagen IQis carcinogenic to cynomolgus
and rhesus monkeys after oral administra-
tion. IQ induced tumors in 55% of the
animals at the 10 mg/kg dose level, and in
95% ofthe animals at the 20 mg/kg dose.
In addition, the average latent period at
the high dose was 43 months, which is
about one-seventh ofthe life span ofthese
animals (25- to 30-year life expectancy).
The tumors were all hepatocellular carci-
nomas, and metastases to the lungs oc-
curred in six cases. These tumors were
induced by doses that were not overtly
toxic and the high dose used was not the
maximum tolerated dose. Generally, the
tumor nodules in the animals exhibited a
well- to moderately well-differentiated
hepatocellular carcinoma. The liver paren-
chyma that was not involved with neoplas-
tic changes was relatively normal, except
for clear-cell foci, which were commonly
seen. With the exception of moderately
enlarged lymph nodes of the colonic sub-
mucosa and mesentery, no other gross
abnormalities were seen in the monkeys
receiving IQ necropsied to date. Micro-
scopically these nodes showed reactive
hyperplasia and large lymphoid follicles.
The only other microscopic abnormalities
that have been demonstrated in these IQ-
treated monkeys are focal myocardial
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toxic cardiomyopathy (11).
Although the doses used in these exper-
iments are much higher than those report-
ed in several studies (2) of fried ground
beef (0.02-0.6 ng/g) or broiled sardines
(4.9-20 ng/g), IQ is only 1 of 19 HAAs
identified in cooked meat. In addition, the
tumors induced by IQ in nonhuman pri-
mates occurred in a high percentage ofthe
treated animals in only about one-seventh
of their life span. Furthermore, two of the
other HAAs occurring in greater amounts
in cooked meats, MeIQx and PhIP, are
carcinogenic in rodents and are currently
also under evaluation for carcinogenic
activity in nonhuman primates (6,7,9,12).
Thus, we conclude that the food mutagen
IQ is a potent hepatocarcinogen when
administered to nonhuman primates and is
a potential carcinogen for humans.
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